4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-003036
President, CMO gave up 3,355 shares (to pay taxes)
- President, CMO acquired 9,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huang Jane President, CMO | 2025-04-04 | Option exercise | +9,375 | 78,232 | D | ||
| Huang Jane President, CMO | 2025-04-04 | Shares withheld for taxes | −3,355 | $0.68 | $2,265 | 74,877 | D |
| Derivatives | |||||||
| Huang Jane President, CMO | 2025-04-04 | Option exercise · Restricted Stock Unit | −9,375 | 37,500 | D | ||
Loading xslF345X05/primarydocument.xml…